General Information
Revision date
2014-02-04
Product name
Alkali Tetraborates
Product Synonyms
X-Ray flux
Chemical name
Alkali Tetraborates
supplier name
Klen International (74) Pty Ltd
Icons in SDS
Company Information
company name
Klen International (74) Pty Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
info@klen.com.au
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H319, H360FD
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
2.1 Classification of the substance or mixture
ASCC (SafeWork Australia) Self Classification – hazardous (Repr. Cat 2) Australian Dangerous goods Classification – not a dangerous good SUSMP Poison Schedule: S5
CLP CLASSIFICATION
Self-classification based on the classification criteria provided in CLP Repr. Cat. 1B; H360 FD: May damage fertility or the unborn child Specific concentrations limits Repr. 1B; H360FD C ≥4.5% Eye irrit. Cat. 2; H319: Causes serious eye irritation Specific concentrations limits: C ≥ 10,0 % Xi ; H319 2.1.2. According to Directive 67/548/EEC (DSD): Repr. Cat. 2; R60-R61 R60 may impair fertility R61 may cause harm to the unborn child Xi ; R36 Concentrations limits C ≥4.5% R;R60-61
Hazard statements
R60; R61; R36
Precautionary statements
S45; S53; S26 P201 : Obtain special instructions before use. P202: Do not handle until all safety precautions have been read and understood. P281 : Use personal protective equipment as required. P264 : Wash eyes thoroughly after handling. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 If exposed or concerned get medical advice/attention P305+P351+P338 IF IN EYES Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337+P313 If eye irritation persists Get medical advice/attention P405 : Store locked up P501 : Dispose of contents/container to in accordance with local regulations.
2.2 Label elements
Labelling according to Regulation (EC) No. 1272/2008 (CLP)
Signal word
Danger Hazard code and statements: H360FD: May damage fertility. May damage the unborn child
2.3 Other hazards
Emergency overview Harmful if swallowed or inhaled. This product may be irritating to the skin, eyes, respiratory tract and mucous membranes. Ingestion may cause gastric or intestinal pain and cramps
Potential health effects
Inhalation is the most significant route of exposure in occupational and other settings. Dermal exposure is not usually a concern because anhydrous borate is poorly absorbed through intact skin. Inhalation Occasional mild irritation effects to nose and throat may occur from inhalation of anhydrous borate dusts at levels higher than 10 mg/m3. Eye contact Anhydrous borate is a serious eye irritant. Skin contact Anhydrous borate does not cause irritation to intact skin. Ingestion Products containing anhydrous borate are not intended for ingestion. Anhydrous borate has low acute toxicity. Small amounts (e.g. a teaspoonful) swallowed accidentally are not likely to cause effects; swallowing amounts larger than that may cause gastrointestinal symptoms. Lithium, in large doses, can cause dizziness and weakness. If a low salt diet is in place, kidney damage can result. Reproductive/Developmental Animal ingestion studies in several species, at high doses, indicate that borates cause reproductive and developmental effects. A human study of occupational exposure to borate dust showed no adverse effect on reproduction. A recent epidemiological study and a peer reviewing report of the past epidemiological studies conducted in China didn‟t show any negative effect of boron on human fertility. Potential ecological effects Large amounts of anhydrous borates can be harmful to plants and other species. Therefore releases to the environment should be minimised. Signs and symptoms of exposure Symptoms of accidental over-exposure to anhydrous borates have been associated with ingestion or absorption through large areas of damaged skin. These may include nausea, vomiting, and diarrhoea, with delayed effects of skin redness and peeling (see section 11).